Resource library

Break down the Dementia, Seizure, + Total Brain Atrophy reports to show how NeuroQuant enhances clinical analysis of neurological atrophy for various conditions

Are you curious how you can get an automated FLAIR lesion segmentation and quantification analysis straight to your PACS? Watch now!

Curious about NeuroQuant MVID? Watch our latest demo to see how this powerful tool simplifies brain volume and microhemorrhage identification. 🔍

Watch Dr. Suzie Bash demonstrate the powerful capabilities of NeuroQuant ARIA and its impact on dementia screenings and treatment decisions.

Transform brain tumor management with automated and reliable quantification and monitoring of tumor volumes. Watch how it works!

Discover the game-changing benefits of OnQ Prostate! Curious how it outperforms traditional methods? Explore everything you need to know about OnQ Prostate.

Read more about RSNA 2023: AI in Alzheimer’s Disease – From Early Detection to ARIA

Download and configure appropriate NeuroQuant® and NeuroQuant MS® settings for your imaging scanner.

Dr. Seibert discusses Restriction Spectrum Imaging (RSI) and how it has several potential applications in the diagnosis and treatment of prostate cancer.

Dr. Suzie Bash reviews the new NeuroQuant^® MS quantitative imaging report and its use in the diagnosis and treatment of multiple sclerosis.

An expert panel of neuroradiologists reviews the use of automated volumetric post-processing for the diagnosis and longitudinal assessment of MS.

Dr. Suzie Bash, neuroradiologist at RadNet, uses NeuroQuant and other tools in her review of seven dementia patient cases.

Micki Maes discusses the new features in our latest NeuroQuant® software release and examines case studies that show how these help can physicians.

Dr. Schwartzberg shares cases from his practice at Imaging Healthcare Specialists where the use of OnQ™ Prostate has resulted in more accurate PI-RADS scoring.

We reviewed two NeuroQuant^® reports, along with the LesionQuant FLAIR Lesion report for assessing COVID-19 patient follow-up and research.

A look at the latest features added in NeuroQuant^® 3.0 and LesionQuant 3.0.

Dr. James Brewer shares his experience of using NeuroQuant^® and how it is helping to improve physician assessment of neurodegenerative disease.